Showing results (531-540 of 569) with videos related to
Sort By:
Pageof 57
Cancer Research|March 3, 2007
In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitorsSwee Y Sharp, Kathy Boxall, Martin Rowlands, et al.British Journal of Cancer|March 24, 2026
Self-help cognitive behavioural therapy for hot flushes and night sweats during androgen deprivation therapy for prostate cancer: the MANCAN2 randomized controlled trialSimon J Crabb, Alannah Morgan, Evgenia Stefanopoulou, et al.Environmental Health Perspectives|May 15, 2009
Impacts of climate change on indirect human exposure to pathogens and chemicals from agricultureAlistair B A Boxall, Anthony Hardy, Sabine Beulke, et al.Science Translational Medicine|December 1, 2021
Response to comment on "Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics"Jonas Bovijn, Kristi Krebs, Chia-Yen Chen, et al.Archives of Toxicology|February 16, 2026
Building trust in the integration of artificial intelligence into chemical risk assessment: findings from the 2024 ECETOC workshopTimothy W Gant, Alistair Boxall, Daniel Burgwinkel, et al.JAMA Cardiology|November 16, 2017
Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese AdultsIona Y Millwood, Derrick A Bennett, Michael V Holmes, et al.Nature Geoscience|August 11, 2025
Outburst of a subglacial flood from the surface of the Greenland Ice SheetJade S Bowling, Malcolm McMillan, Amber A Leeson, et al.Integrated Environmental Assessment and Management|February 23, 2018
Toward sustainable environmental quality: Identifying priority research questions for Latin AmericaTatiana Heid Furley, Julie Brodeur, Helena C Silva de Assis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2012
CCT244747 is a novel potent and selective CHK1 inhibitor with oral efficacy alone and in combination with genotoxic anticancer drugsMike I Walton, Paul D Eve, Angela Hayes, et al.Oncotarget|February 9, 2017
Upregulated WEE1 protects endothelial cells of colorectal cancer liver metastasesPeter J Webster, Anna T Littlejohns, Hannah J Gaunt, et al.Pageof 57